197 related articles for article (PubMed ID: 12239444)
1. Small cell lung cancer: defining a role for emerging platinum drugs.
Schiller JH
Oncology; 2002; 63(2):105-14. PubMed ID: 12239444
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
Sasaki Y; Shinkai T; Eguchi K; Tamura T; Ohe Y; Ohmori T; Saijo N
Cancer Chemother Pharmacol; 1991; 27(4):263-70. PubMed ID: 1847845
[TBL] [Abstract][Full Text] [Related]
4. Review of therapeutic trials of carboplatin in lung cancer.
Bunn PA
Semin Oncol; 1989 Apr; 16(2 Suppl 5):27-33. PubMed ID: 2541506
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
Genestreti G; Tiseo M; Kenmotsu H; Kazushige W; Di Battista M; Cavallo G; Carloni F; Bongiovanni A; Burgio MA; Casanova C; Metro G; Scarpi E; Korkmaz T; Selcuk S; Roopa K; Califano R
Clin Lung Cancer; 2015 Nov; 16(6):e223-8. PubMed ID: 25983005
[TBL] [Abstract][Full Text] [Related]
6. [Evidence based chemotherapy for lung cancer].
Watanabe H; Saijo N
Gan To Kagaku Ryoho; 2000 Jan; 27(1):30-43. PubMed ID: 10660731
[TBL] [Abstract][Full Text] [Related]
7. The role of carboplatin in the treatment of small-cell lung cancer.
Ettinger DS
Oncology (Williston Park); 1998 Jan; 12(1 Suppl 2):36-43. PubMed ID: 9516610
[TBL] [Abstract][Full Text] [Related]
8. Current status of clinical trials for small cell lung cancer.
Fischer B; Arcaro A
Rev Recent Clin Trials; 2008 Jan; 3(1):40-61. PubMed ID: 18474014
[TBL] [Abstract][Full Text] [Related]
9. Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma.
Yamada SM; Yamada S; Takahashi H; Teramoto A; Nakayama H
J Neurooncol; 2005 Feb; 71(3):259-65. PubMed ID: 15735914
[TBL] [Abstract][Full Text] [Related]
10. Platinum combined with radiation therapy in small cell lung cancer: focusing like a laser beam on crucial issues.
Turrisi AT
Semin Oncol; 1994 Jun; 21(3 Suppl 6):36-42. PubMed ID: 8052872
[TBL] [Abstract][Full Text] [Related]
11. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
12. Platinum compounds in the treatment of advanced breast cancer.
MartÃn M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
13. Current standards of care in small-cell and non-small-cell lung cancer.
Schiller JH
Oncology; 2001; 61 Suppl 1():3-13. PubMed ID: 11598409
[TBL] [Abstract][Full Text] [Related]
14. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
Sandler AB
Semin Oncol; 1998 Feb; 25(1 Suppl 2):38-41. PubMed ID: 9535210
[TBL] [Abstract][Full Text] [Related]
15. Advances in chemotherapy for small cell lung cancer: single-agent activity of newer agents.
Argiris A; Murren JR
Cancer J; 2001; 7(3):228-35. PubMed ID: 11419031
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with small-cell lung cancer: from meta-analyses to clinical practice.
Rossi A; Martelli O; Di Maio M
Cancer Treat Rev; 2013 Aug; 39(5):498-506. PubMed ID: 23084098
[TBL] [Abstract][Full Text] [Related]
17. Current status and future prospects for satraplatin, an oral platinum analogue.
Choy H; Park C; Yao M
Clin Cancer Res; 2008 Mar; 14(6):1633-8. PubMed ID: 18347164
[TBL] [Abstract][Full Text] [Related]
18. Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance.
Stordal B; Peters G; Davey R
Genes Chromosomes Cancer; 2006 Dec; 45(12):1094-105. PubMed ID: 16967470
[TBL] [Abstract][Full Text] [Related]
19. Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin.
Tang CH; Parham C; Shocron E; McMahon G; Patel N
Cancer Chemother Pharmacol; 2011 Jun; 67(6):1389-400. PubMed ID: 20809122
[TBL] [Abstract][Full Text] [Related]
20. Clinical experiences with carboplatin (paraplatin) in lung cancer.
Bunn PA
Semin Oncol; 1992 Feb; 19(1 Suppl 2):1-11. PubMed ID: 1329216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]